SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/07/22 Argan Inc. 8-K:2,9 12/07/22 11:416K Toppan Merrill Bridge/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 49K 2: EX-99.1 Miscellaneous Exhibit HTML 234K 6: R1 Document and Entity Information HTML 47K 9: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- agx-20221207x8k_htm XML 16K 8: EXCEL IDEA Workbook of Financial Reports XLSX 8K 4: EX-101.LAB XBRL Labels -- agx-20221207_lab XML 46K 5: EX-101.PRE XBRL Presentations -- agx-20221207_pre XML 31K 3: EX-101.SCH XBRL Schema -- agx-20221207 XSD 13K 10: JSON XBRL Instance as JSON Data -- MetaLinks 11± 17K 11: ZIP XBRL Zipped Folder -- 0001558370-22-018448-xbrl Zip 28K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of Earliest Event Reported): i December 7, 2022
i ARGAN, INC.
(Exact Name of Registrant as Specified in its Charter)
| | | | |
i Delaware |
|
| i 13-1947195 | |
(State or Other Jurisdiction of Incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
| | |
| i 20850 | |
(Address of Principal Executive Offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: ( i 301) i 315-0027
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
| |
i ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
i ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
i ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| | | | |
Title of Each Class: | | Trading Symbol(s): | | Name of Each Exchange on |
i Common Stock, $0.15 Par Value | | i AGX | | i New York Stock Exchange |
Item 2.02. Results of Operations and Financial Condition.
On December 7, 2022, Argan, Inc. (“Argan”) issued a press release announcing its financial results for the three months ended October 31, 2022. A copy of Argan’s Press Release is attached to this report as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
Exhibit No. |
| Description |
99.1 |
| |
104 | | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ||||||
|
| ARGAN, INC. | ||||
Date: December 7, 2022 |
|
| By: |
| /s/ Richard H. Deily | |
|
|
| ||||
|
|
| Senior Vice President, Chief Financial Officer, Treasurer and Corporate Secretary |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 12/7/22 | None on these Dates | ||
10/31/22 | ||||
List all Filings |